A detailed history of Toroso Investments, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Toroso Investments, LLC holds 6,133 shares of CRL stock, worth $1.22 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,133
Previous 5,297 15.78%
Holding current value
$1.22 Million
Previous $1.44 Million 11.78%
% of portfolio
0.02%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $172,542 - $224,658
836 Added 15.78%
6,133 $1.27 Million
Q1 2024

May 15, 2024

BUY
$203.52 - $273.43 $538,513 - $723,495
2,646 Added 99.81%
5,297 $1.44 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $176,365 - $256,036
1,072 Added 67.89%
2,651 $626,000
Q3 2023

Nov 15, 2023

BUY
$194.44 - $217.61 $33,832 - $37,864
174 Added 12.38%
1,579 $309,000
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $16,533 - $18,922
90 Added 6.84%
1,405 $295,000
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $11,705 - $15,855
61 Added 4.86%
1,315 $265,000
Q4 2022

Feb 15, 2023

BUY
$197.11 - $250.07 $22,273 - $28,257
113 Added 9.9%
1,254 $273,000
Q3 2022

Nov 23, 2022

BUY
$182.44 - $250.54 $9,486 - $13,028
52 Added 4.78%
1,141 $225,000
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $14,289 - $21,168
-70 Reduced 6.04%
1,089 $233,000
Q1 2022

May 20, 2022

BUY
$255.51 - $362.11 $38,837 - $55,040
152 Added 15.09%
1,159 $329,000
Q4 2021

Feb 16, 2022

BUY
$351.38 - $448.68 $66,059 - $84,351
188 Added 22.95%
1,007 $379,000
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $90,924 - $111,825
244 Added 42.43%
819 $338,000
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $169,147 - $213,698
575 New
575 $213,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.